Search results for "SARS-COV-2"

showing 10 items of 1204 documents

Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results From an Italian Multicenter Study

2021

Background: Many aspects of SARS-CoV-2 infection in children and adolescents remain unclear and optimal treatment is debated. The objective of our study was to investigate epidemiological, clinical and therapeutic characteristics of pediatric SARS-CoV-2 infection, focusing on risk factors for complicated and critical disease.Methods: The present multicenter Italian study was promoted by the Italian Society of Pediatric Infectious Diseases, involving both pediatric hospitals and general pediatricians/family doctors. All subjects under 18 years of age with documented SARS-CoV-2 infection and referred to the coordinating center were enrolled from March 2020.Results: As of 15 September 2020, 75…

Pediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MIS-CDisease030204 cardiovascular system & hematologyPediatrics03 medical and health sciences0302 clinical medicinechildren030225 pediatricsEpidemiologymedicinebookOriginal Researchmultisystem inflammatory syndromeMIS-C COVID-19business.industrySARS-CoV-2 infectionDisease progressionlcsh:RJ1-570COVID-19lcsh:PediatricsSettore MED/38Icu admissionCOVID-19; MIS-C; SARS-CoV-2 infection; children; multisystem inflammatory syndromeMulticenter studyPediatrics Perinatology and Child HealthPediatric Infectious Diseasebook.journalbusiness
researchProduct

Coagulation Parameters: An Efficient Measure for Predicting the Prognosis and Clinical Management of Patients with COVID-19

2020

Background. COVID-19 is an ongoing global pandemic. Since the detection of the first cases of coronavirus disease 2019 (COVID-19) in Wuhan, China, the current pandemic has affected more than 25.3 million people worldwide. The aim of this study was to evaluate the relationship between coagulation abnormalities and prognosis in a cohort of patients with COVID-19. Methods. We performed a retrospective cohort study of 3581 patients admitted to Hospital La Paz (Madrid, Spain) due to respiratory infection by severe acute respiratory syndrome coronavirus from the beginning of the current pandemic to 15 July 2020. Results. Of the 3581 study patients, 48.94% were men, and 19.80% were healthcare work…

Pediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)coronaviruslcsh:Medicine030204 cardiovascular system & hematologymedicine.disease_causeArticle03 medical and health sciences0302 clinical medicineInterquartile rangePandemicMedicine030212 general & internal medicinecoagulationCoronavirusSARS-CoV-2business.industrylcsh:RCOVID-19Respiratory infectionRetrospective cohort studyGeneral MedicineCoagulationCOVID-19 SARS-CoV-2 coagulation coronavirusCohortbusiness
researchProduct

Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020

2020

A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.

Pediatricsmedicine.medical_specialtyEpidemiologyPneumonia Viralrespiratory pathogensdifferential diagnosiSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeDisease OutbreaksDiagnosis DifferentialBetacoronavirusCOVID-19 TestingVirologydifferential diagnosisInfluenza HumanMedicineHumansMass Screeningrapid molecular assayRespiratory Tract InfectionsMass screeningCoronavirusTravelbiologyCOVID-19 ; respiratory pathogens ; differential diagnosis ; SARS-CoV-2 ; rapid molecular assaybusiness.industryTransmission (medicine)SARS-CoV-2Clinical Laboratory TechniquesRespiratory diseasePublic Health Environmental and Occupational HealthOutbreakCOVID-19medicine.diseasebiology.organism_classificationPneumoniamedicine.anatomical_structureItalyMolecular Diagnostic TechniquesPopulation SurveillancebusinessCoronavirus InfectionsBetacoronavirusRapid CommunicationAlgorithmsRespiratory tractEurosurveillance
researchProduct

Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature

2021

Kawasaki disease (KD) is a vasculitis of unknown origin of small and medium caliber blood vessels, especially involving coronary arteries and is the leading cause of acquired heart disease in childhood in developed countries. Although rarely, it can recur: most recurrences occur within 2 years of the initial episode. No data are available on incidence of recurrent KD in Europe and multiple recurrences are rarely seen. We reviewed the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection. We believe that in our case SARS Cov2 acted as a trigger capable to determine, in a genetically susceptible individual…

Pediatricsmedicine.medical_specialtyHeart diseaseSettore MED/17 - Malattie InfettiveDiseaseReviewMucocutaneous Lymph Node SyndromePediatricsRJ1-57003 medical and health sciences0302 clinical medicineRecurrence030225 pediatricsSars-Cov2EpidemiologymedicineHumans030212 general & internal medicineskin and connective tissue diseasesChildPandemicsbusiness.industrySARS-CoV-2Incidence (epidemiology)IncidenceInfantmedicine.diseaseSars-Cov2Coronary arteriesmedicine.anatomical_structureRecurrent Kawasaki diseaseChild PreschoolKawasaki diseaseKawasaki disease recurrenceVasculitisbusinessCovid-19Medical literature
researchProduct

Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwid…

2020

Pediatric inflammatory multisystem syndrome (PIMS) is a new entity in children, likely associated with previous coronavirus disease 19 (COVID-19) infection. Most of the reports about PIMS come from countries particularly hit by the COVID-19 pandemic. Our aim was to investigate the nature of inflammatory syndromes in Poland (country with low COVID-19 prevalence) and to perceive the emergence of PIMS in our country. On 25 May 2020, we launched a nationwide survey of inflammatory syndromes in children for retrospective (since 4 March 2020) and prospective data collection. Up to 28 July, 39 reported children met the inclusion criteria. We stratified them according to age (&lt

Pediatricsmedicine.medical_specialtyPIMS; MIS-C; SARS-CoV-2; COVID-19; Kawasaki disease; surveyCoronavirus disease 2019 (COVID-19)lcsh:MedicineProspective dataMIS-CContext (language use)Disease030204 cardiovascular system & hematologyNationwide surveyArticle03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesPandemicmedicinesurvey030212 general & internal medicinePIMSKawasaki diseaseSARS-CoV-2business.industrylcsh:RCOVID-19General Medicinemedicine.diseaseKawasaki diseaseDifferential diagnosisbusinessJournal of Clinical Medicine
researchProduct

Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature

2021

Abstract Objectives To describe clinical characteristics, laboratory tests, radiological data and outcome of pediatric cases with SARS-CoV-2 infection complicated by neurological involvement. Study design A computerized search was conducted using PubMed. An article was considered eligible if it reported data on pediatric patient(s) with neurological involvement related to SARS-CoV-2 infection. We also described a case of an acute disseminated encephalomyelitis (ADEM) in a 5-year-old girl with SARS-CoV-2 infection: this case was also included in the systematic review. Results Forty-four articles reporting 59 cases of neurological manifestations in pediatric patients were included in our revi…

Pediatricsmedicine.medical_specialtySubarachnoid hemorrhagePneumonia ViralContext (language use)ReviewPediatricsRJ1-570Transverse myelitismedicineHumansChildNervous System DiseaseAutoimmune encephalitisIntracerebral hemorrhageSARS-CoV-2business.industryCranial nervesCOVID-19MeningoencephalitisGeneral Medicinemedicine.diseaseSARS-CoV-2.Acute disseminated encephalomyelitisNervous System DiseasesbusinessHumanItalian Journal of Pediatrics
researchProduct

Reduced Self-Awareness Following a Combined Polar and Paramedian Bilateral Thalamic Infarction. A Possible Relationship With SARS-CoV-2 Risk of Conta…

2020

Reduced self-awareness is a well-known phenomenon investigated in patients with vascular disease; however, its impact on neuropsychological functions remains to be clarified. Importantly, selective vascular lesions provide an opportunity to investigate the key neuropsychological features of reduced self-awareness in neurocognitive disorders. Because of its rarity, we present an unusual case of a woman affected by a combined polar and paramedian bilateral thalamic infarction. The patient underwent an extensive neuropsychological evaluation to assess cognitive, behavioral, and functional domains, with a focus on executive functions. She was assessed clinically in the acute phase and after 6 m…

Pediatricsmedicine.medical_specialtylcsh:BF1-990case study; executive functions; polar and paramedian thalamic infarction; reduced self-awareness; SARS-CoV-2reduced self-awarenessCase Report050105 experimental psychologycase study03 medical and health sciences0302 clinical medicinepolar and paramedian thalamic infarctionmedicinePsychology0501 psychology and cognitive sciencesApathyStrokeGeneral PsychologyDepression (differential diagnoses)SARS-CoV-2Vascular disease05 social sciencesNeuropsychologyexecutive functionsmedicine.diseaseExecutive functionslcsh:Psychologymedicine.symptomPsychologyNeurocognitive030217 neurology & neurosurgeryExecutive dysfunctionFrontiers in Psychology
researchProduct

COVID-19 … What are drugs and strategies now?

2020

From February 2019 the World faces the Covid19 pandemic. The data in our possession are still insufficient to effectively combat this pathology. The gold standard for diagnosis remains molecular testing, while clinical and instrumental and serological diagnostics are highly nonspecific leading to a slowdown in the battle against covid19.[3] Can Artificial Intelligence (AI) and Machine Learning (ML) help us? The use of large databases to cross-reference data to stratify the diagnostic scores, to quickly differentiate a critical Covid-19 patient from a non-critical one is the challenge of the future. All to achieve better management of resources in the field and a more effective therapeutic a…

Pharmaceutical PreparationsArtificial IntelligenceSARS-CoV-2CorrespondenceCOVID-19HumansPandemics
researchProduct

Deciphering the Potential of Pre and Pro-Vitamin D of Mushrooms against Mpro and PLpro Proteases of COVID-19: An In Silico Approach

2022

Vitamin D’s role in combating the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus causing COVID-19, has been established in unveiling viable inhibitors of COVID-19. The current study investigated the role of pre and pro-vitamin D bioactives from edible mushrooms against Mpro and PLpro proteases of SARS-CoV-2 by computational experiments. The bioactives of mushrooms, specifically ergosterol (provitamin D2), 7-dehydrocholesterol (provitamin-D3), 22,23-dihydroergocalciferol (provitamin-D4), cholecalciferol (vitamin-D3), and ergocalciferol (vitamin D2) were screened against Mpro and PLpro. Molecular docking analyses of the generated bioactive protease complexes unr…

Pharmaceutical Scienceedible mushroomsMolecular Dynamics SimulationViral Nonstructural ProteinsAnalytical Chemistrypro-vitamin-DErgosterolDrug DiscoveryEndopeptidasespre-vitamin-DHumansProtease InhibitorsPhysical and Theoretical ChemistryVitamin DSARS-CoV-2Organic ChemistryProvitaminsin-silico studiesSettore CHIM/08 - Chimica FarmaceuticaCOVID-19 Drug TreatmentMolecular Docking SimulationChemistry (miscellaneous)Molecular MedicineAgaricalesedible mushrooms; SARS-CoV-2; pre-vitamin-D; pro-vitamin-D; in-silico studiesPeptide HydrolasesMolecules; Volume 27; Issue 17; Pages: 5620
researchProduct

Cardiovascular and Cardioprotective Agents in 2021

2021

Pharmacology2019-20 coronavirus outbreakCardiotonic AgentsCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cardiovascular AgentsPharmacologyCardiovascular SystemCardiovascular DiseasesDrug DiscoveryCardiovascular agentHumansMedicineCardioprotective AgentbusinessCurrent Pharmaceutical Design
researchProduct